Announced
Completed
Sequoia China led a $43m Series B round in BoomRay Pharmaceuticals.
Synopsis
Sequoia China, a venture capital firm, led a $43m Series B round in BoomRay Pharmaceuticals, a biotech company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.